Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-10

Clinical Trial Update: AF CRT +/- Nimorazole in HNSCC [Phase 3]

View source ↗

Summary

Phase 3 trial update for nimorazole added to chemoradiation in locally advanced HPV-negative head and neck squamous cell carcinoma; status and results are not p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nimorazole (nimorazole)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers | Phase 3 | Status: UNKNOWN